Calypte Biomedical Corp (fka CBMC)

[AxiomOne]

Its hard to understand people like this. I can at least respect Reads posts because they are intellectual. Obviously qtr 1 results are already priced into todays market for Calytpe. Everyone knows they are going to be obsolete - no surprise there. However, they could come out with new projections, approvals, sales, etc. I really don't see this going back down unless they are unable to receive approval in China. Possibility of good news definately outweighs possibility of bad news.